Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amerx Health Care is a medical products company specializing in advanced wound and skin care solutions for the healthcare industry. Founded in 1993, the company is recognized for its AMERIGEL product line, which incorporates Oakin, a proprietary oak extract known for its natural antimicrobial and healing properties. Their portfolio includes hydrogel wound dressings, barrier lotions, and compression garments designed to treat conditions such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers. Amerx primarily serves clinicians in podiatry, wound care centers, and long-term care facilities. The company focuses on providing cost-effective, evidence-based treatments that simplify wound management protocols and improve patient compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amerx Health Care.